|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Guest Editorial: At the Governance Crossroad
Author(s)Joseph F. Noferi, Esq.
by Joseph Noferi, Pharmacia GS API Biopharma
Advertisement
Articles in this issue
almost 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mousealmost 23 years ago
Reducing Costs by Facility Designalmost 23 years ago
Guidelines for Optimization and Scale-Up in Preparative Chromatographyalmost 23 years ago
Survival Strategies: Board Compensation Changing with the TimesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
3
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
4
Charles River Incubator Cohort to Accelerate CGT Development
5

